We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Commissioner nominee Scott Gottlieb will recuse himself for one year from decisions relating to more than 20 companies, including large drugmakers, according to his ethics disclosure form. Read More
Sen. Claire McCaskill (D-Mo.) has opened a congressional investigation into the top five manufacturers of opioids, saying the overdose epidemic is a “direct result” of the companies’ sales and marketing strategies over the past two decades. Read More
Scott Gottlieb has met with the chair of the Senate committee presiding over his confirmation as the next FDA commissioner, Sen. Lamar Alexander (R-Tenn.). Read More